Clinical Application Study of Different Doses of Remimazolam Combined With Sevoflurane in Pediatric Adenoidectomy

ImportanceEffective anesthesia with minimal side effects is essential for pediatric patients undergoing adenoidectomy.MethodsA single-center, prospective, randomized controlled trial was conducted at Gaoming District People's Hospital (China, January 2022-October 2023). Two-hundred fifty-six children (ASA I-II, age 3-12 years) scheduled for elective plasma radiofrequency adenoidectomy were randomized to 4 groups (n = 64 each). Group A received 0.9% normal saline; groups B, C, and D received continuous infusions of benzenesulfonate remimazolam at 0.4, 0.6, and 0.8 mg/kg/h, respectively, combined with 6% sevoflurane for induction and 2% to 3% for maintenance. Primary outcomes were emergence time and postanesthesia care unit (PACU) stay. Secondary outcomes included incidence of adverse events, peak Pediatric Anesthesia Emergence Delirium (PAED) scores, and parental satisfaction.ResultsMedian awakening time was longer in groups B, C, and D than in group A (<i>P</i> < .001). PACU stay was shorter in groups C and D versus group A (<i>P</i> < .05). Postoperative pain scores (Face, Legs, Activity, Cry, and Consolability) were lower in groups C and D than in groups A and B (<i>P</i> < .05). Peak PAED scores were lower in groups B, C, and D than in group A (<i>P</i> < .05); negative behavioral changes on postoperative day 3 were also reduced (<i>P</i> < .05). Parental satisfaction was higher in groups B, C, and D than in group A (<i>P</i> < .001). No serious adverse events occurred.Conclusion and RelevanceBenzenesulfonate remimazolam (0.6 mg/kg/h) combined with sevoflurane provides effective, safe anesthesia for pediatric plasma radiofrequency adenoidectomy, balancing induction efficacy, sedation depth, and safety. This regimen reduces emergence delirium, postoperative pain, and negative behavioral changes while enhancing parental satisfaction, supporting its use in pediatric adenoidectomy and warranting further investigation in other pediatric procedures.

Authors

Institutions

Publication Details

Journal
Journal of Otolaryngology - Head and Neck Surgery
Published
2025-10-01
DOI
https://doi.org/10.1177/19160216251383860
Primary Topic
Anesthesia and Neurotoxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Application Study of Different Doses of Remimazolam Combined With Sevoflurane in Pediatric Adenoidectomy

Wesley Liao, Y.-A. Chen, Min Wang, Meiyun Tan et al.
Journal of Otolaryngology - Head and Neck Surgery
Anesthesia and Neurotoxicity Research
article

Clinical Application Study of Different Doses of Remimazolam Combined With Sevoflurane in Pediatric Adenoidectomy

Wesley Liao, Y.-A. Chen, Min Wang, Meiyun Tan, Anguo Zhong
article en

Abstract

ImportanceEffective anesthesia with minimal side effects is essential for pediatric patients undergoing adenoidectomy.MethodsA single-center, prospective, randomized controlled trial was conducted at Gaoming District People's Hospital (China, January 2022-October 2023). Two-hundred fifty-six children (ASA I-II, age 3-12 years) scheduled for elective plasma radiofrequency adenoidectomy were randomized to 4 groups (n = 64 each). Group A received 0.9% normal saline; groups B, C, and D received continuous infusions of benzenesulfonate remimazolam at 0.4, 0.6, and 0.8 mg/kg/h, respectively, combined with 6% sevoflurane for induction and 2% to 3% for maintenance. Primary outcomes were emergence time and postanesthesia care unit (PACU) stay. Secondary outcomes included incidence of adverse events, peak Pediatric Anesthesia Emergence Delirium (PAED) scores, and parental satisfaction.ResultsMedian awakening time was longer in groups B, C, and D than in group A (<i>P</i> < .001). PACU stay was shorter in groups C and D versus group A (<i>P</i> < .05). Postoperative pain scores (Face, Legs, Activity, Cry, and Consolability) were lower in groups C and D than in groups A and B (<i>P</i> < .05). Peak PAED scores were lower in groups B, C, and D than in group A (<i>P</i> < .05); negative behavioral changes on postoperative day 3 were also reduced (<i>P</i> < .05). Parental satisfaction was higher in groups B, C, and D than in group A (<i>P</i> < .001). No serious adverse events occurred.Conclusion and RelevanceBenzenesulfonate remimazolam (0.6 mg/kg/h) combined with sevoflurane provides effective, safe anesthesia for pediatric plasma radiofrequency adenoidectomy, balancing induction efficacy, sedation depth, and safety. This regimen reduces emergence delirium, postoperative pain, and negative behavioral changes while enhancing parental satisfaction, supporting its use in pediatric adenoidectomy and warranting further investigation in other pediatric procedures.

Journal of Otolaryngology - Head and Neck SurgeryVol. 54
Foshan Hospital of TCM (CN), First People's Hospital of Foshan (CN), Foshan Second People's Hospital (CN), Boai Hospital of Zhongshan (CN)
Openalex Percentile: Top 64%
Anesthesia and Neurotoxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.